pathwire
 
 
 
 
New Report: A Status of Quality in Life Sciences  _________________________________________________________     

  

Every quarter, our team at PathWise issues a new survey polling 25,000 quality professionals in the life science industry. Covering issues from CAPA to Risk Management, our survey responses provide an inside look into how quality departments and budgets are allocated and how life science organizations are currently managing their quality systems.

 

As a special thank you to our valued readership, we've compiled our 2011 quality survey results into a downloadable report. We hope you find this information of benefit for your quality system management efforts into 2012 and beyond.

 

Best wishes for a compliant, effective and efficient new year!

 

Biopharma Automation: Transformation
Through Training
_________________________________________________________     

  

Biopharmaceutical manufacturing is poised to enter a more efficient and robust phase. New technologies, particularly in the area of automation, are enabling operations that are faster and better understood than in the

past. If biomanufacturers are to keep up with, and leverage, technological advances, they must provide effective training for their key

personnel.

 

This special PDF-with additional links to web-based resources-looks at the importance of automation technical training and how it can provide biopharma manufacturers with clear competitive advantages.

 
Download the report.
Medical Devices to Watch in 2012 
_________________________________________________________    
 

 

The year 2012 might see the much-hyped therapies of stem cells and gene therapy become clinical realities. Data showing that heart-derived stem cells improved the cardiac output of heart failure patients with myocardial infarction seemed to be a true breakthrough.

 

Check out some of the most promising and innovative new medical devices to track in 2012


Read complete article.  

ICH Q11 Guidance Nears Final Approval After Comments Prompt Changes
_________________________________________________________     

  

The final version of ICH's drug substance development and manufacturing guideline Q11 is nearing Step 4 clearance by the regulatory agencies in the three ICH regions following some significant changes the Expert Working Group (EWG) has made to the Step 2 draft based on the comments received.

    

Read complete article.
Proposed boost to FDA's budget could turn the heat down on user fee negotiations
_________________________________________________________     

  

FDA negotiations with the medical device industry over user fees may get a little relief if a bill granting the watchdog agency a boost to its 2012 budget gets the green light from Congress.

 

As part of a bill from a House/Senate conference negotiation last month, the FDA's pocketbook would not only avoid getting a trim - the agency would get a $50 million boost over last year's budget.
    

Read complete article.
FDA Seeks Input on Device Classification System
_________________________________________________________     

  

Recently, the Food and Drug Administration (FDA) opened up a public comment period, extending to mid-January, to get perspective on whether the information gathered during reclassification submissions of medical devices is necessary and useful, whether it's gauge on timing and burden is appropriate, and how to improve on the process and minimize burden. 

 

According to an article from MassDevice, FDA "is also looking for ideas on how to use automated collection techniques and other forms of information technology to make the submission process easier." 

 

Read complete article.
Poll: Do you include employee names or employee titles in your investigation reports?   
_________________________________________________________     
 

When conducting and documenting quality investigations, the inclusion of specific employee names is often up for debate.  Do you include employee names or employee titles in your investigation reports?

 

Take the poll.

Monthly Newsletter 

PathWise, Inc. 

December 2011 

 image


Upcoming Events

CAPA for Life Sciences 

 
These 2-day courses are designed to meet the requirements mandated by regulatory agencies to effectively investigate and locate causes and correct them.
        
Feb. 15-16, 2012
Switzerland

March 13-14, 2012
Chicago, IL

 

June 12-13, 2012
Boston, MA

 

Sept. 4-5, 2012
Ireland

 

Nov. 12-13, 2012
San Diego, CA
 
For more information or to register.

_________________

Audit Management

This 2-day course is designed to to train and prepare individuals to manage the quality audit process through reading, lecture, discussion, role playing, and practical exercises.


March 15-16, 2012
Chicago, IL
 

June 14-15, 2012
Boston, MA

Sept. 6-7, 2012
Ireland

Nov. 14-15, 2012
San Diego, CA  


For more information or to register.

 

_________________ 



PathWise Webinars
 

 

Integrating FDA and Trending
Requirements into your CAPA System 

 

This session offers attendees a how-to approach to effectively integrate the FDAs CAPA and trending requirements, providing them with the skills and tools necessary to develop a strong, sustainable and compliant CAPA System.

__________________

Best Practices to Manage an FDA Inspection
 

When it comes to quality system audits, the level of preparation within your organization can make a significant difference in your level of success. This webinar discusses how to effectively prepare for and manage an FDA inspection. 
 

Download webinars.

 


 

________________________________________________________________________________

                                                                 

 

handbooks

 

These FDA Inspection Guides provide guidance on the inspectional process used to assess various life science manufacturer's compliance with quality system regulations.

 

 

Biotechnology

  • Biotechnology Inspection Guide

Medical Devices

  • QSIT for Medical Devices
  • Electromagnetic Compatibility Aspects of Medical Device Quality Systems
  • Bioresearch Monitoring Inspections of In Vitro Diagnostics Devices
  • Mammography Quality Standards Act Auditor's Guide
  • Medical Device Manufacturers

Pharmaceuticals

  • Microbiological Pharmaceutical Quality Control Labs
  • Pharmaceutical Quality Control Labs
  • Sterile Drug Substance Manufacturers
  • Dosage Form Drug Manufacturers cGMPs
  • Topical Drug Products

Order Online

 
   

________________________________________________________________________________

                                                                  
Facing an uphill battle?   
 

PathWise is a training and consulting firm that works with medical device, pharmaceutical and biotechnology companies in the areas of quality and compliance. We deliver the methodology and tools to ensure compliant, effective and efficient execution of quality system requirements. 
 
  
     Change Control               Risk Management                  Documentation
           

      CAPA                                 QSR                            Audit Management 

 

_______________________________________________________________________________________________________ 

          

                  Please visit us online at www.PathWise.com or call 866.580.PATH for more information